| Cause | Clues (History & Exam) | Intervention |
|---|---|---|
| H's | ||
| Hypovolemia | Trauma, GI bleed (hematemesis, melena), ruptured AAA, ruptured ectopic. Flat neck veins, pale, bloody NG aspirate. | Aggressive IVF boluses. Activate massive transfusion protocol. Blood products 1:1:1. Surgical consult if hemorrhagic. |
| Hypoxia | Pre-arrest desaturation, cyanosis, COPD/asthma history, mucus plug, aspiration event, known difficult airway. | Confirm ETT placement (ETCO₂). Auscultate both lungs. If no breath sounds unilateral → mainstem intubation or PTX. Suction. Increase FiO₂ to 100%. |
| Hydrogen ion (acidosis) | Known DKA, renal failure, severe sepsis, toxic ingestion (methanol, ethylene glycol, ASA). Pre-arrest ABG with pH < 7.1. | Sodium bicarbonate 1 mEq/kg IV push. Ventilate aggressively (blow off CO₂). Treat underlying cause (insulin for DKA, dialysis for renal failure, fomepizole for toxic alcohols). |
| Hyper/Hypokalemia | Renal failure (hyperK), dialysis patient who missed session, recent K⁺ lab, ECG changes (peaked T waves, wide QRS). HypoK: diuretic use, GI losses, prolonged QT. | HyperK: Calcium chloride 1–2g IV push (stabilize membrane) → insulin 10 units + D50 → bicarb → albuterol. HypoK: KCl 40 mEq IV + MgSO₄ 2g IV. |
| Hypothermia | Found down outdoors, drowning, exposure, elderly. Core temp < 30°C (86°F). "Not dead until warm and dead." | Active rewarming: warm IVF (40°C (104°F)), warm humidified O₂, forced-air warming blankets. If < 30°C (86°F): defib may not work until rewarmed → limit to 1 shock attempt, hold meds until temp > 30°C (86°F). Continue CPR. Consider ECMO rewarming if available. This row is accidental hypothermia as the CAUSE of the arrest. After ROSC the logic is different: see post-ROSC temperature control. |
| Hypoglycemia | Diabetic on insulin/sulfonylureas, altered mental status pre-arrest, missed meals, liver failure, adrenal crisis. | D50 (dextrose 50%) 1 amp (25g) IV push. Recheck in 15 min. If no IV access: glucagon 1 mg IM. |
| T's | ||
| Tension pneumothorax | Absent breath sounds unilaterally, JVD, tracheal deviation (late sign), recent central line or thoracentesis, trauma, patient on positive pressure ventilation. | Needle decompression: 14–16G needle, 2nd intercostal space midclavicular line (or 5th ICS anterior axillary). Do NOT wait for CXR. Follow with chest tube (28–32 Fr). |
| Tamponade (cardiac) | Beck's triad: JVD + hypotension + muffled heart sounds. Recent cardiac surgery, pericardial effusion on prior imaging, dialysis patient (uremic pericarditis), trauma, malignancy, post-MI (free wall rupture). | Pericardiocentesis: subxiphoid approach, US-guided. Remove even 20–30 mL → dramatic improvement. In post-surgical: emergent sternotomy (re-open). |
| Toxins | Pill bottles at scene, history of depression/suicidal ideation, drug paraphernalia. Wide QRS (TCAs, Na-channel blockers). Opioid presentation (pinpoint pupils). Bradycardia (beta-blocker, CCB, digoxin). Seizure history (local anesthetic toxicity). | Specific antidotes: Naloxone (opioid), sodium bicarb (TCA -QRS > 100), intralipid 20% (local anesthetic toxicity, lipophilic drug OD), glucagon (beta-blocker), calcium + high-dose insulin (CCB), DigiFab (digoxin). See Toxicology. |
| Thrombosis -coronary (MI) | Pre-arrest chest pain, STEMI on last ECG, known CAD, cardiac risk factors. PEA with organized narrow-complex rhythm on monitor. | Consider emergent PCI (cath lab activation during CPR -some centers do this). If no PCI available: fibrinolytics (tPA 50 mg IV during CPR) -consider if high suspicion and no other cause found. Continue CPR for 60–90 min after lytics. |
| Thrombosis -pulmonary (Category E PE) | Pre-arrest dyspnea + pleuritic pain + tachycardia, recent surgery/immobilization/cancer, known DVT, RV strain on prior echo, dilated RV on bedside echo during CPR. | Systemic thrombolytics: tPA 50 mg IV bolus (can give during CPR). Continue CPR for 60–90 min after lytics to allow time to work. If available: consider surgical embolectomy or catheter-directed therapy. Bedside echo during CPR showing RV dilation supports PE diagnosis. |
| Drug | Dose | Indication |
|---|---|---|
| Epinephrine (Adrenalin) | 1 mg IV q3–5 min | All cardiac arrest rhythms. First-line vasopressor. |
| Amiodarone (Cordarone) | 300 mg IV push (1st dose), 150 mg (2nd dose) | Refractory VFib/pVT after 3+ shocks. |
| Lidocaine | 1–1.5 mg/kg IV, then 0.5–0.75 mg/kg | Alternative to amiodarone for VFib/pVT. |
| Atropine | 1 mg IV q3–5 min (max 3 mg) | Symptomatic bradycardia (NOT for asystole or PEA). |
| Adenosine (Adenocard) | 6 mg rapid IV push → if no effect → 12 mg (two doses only) | Stable SVT. Must use rapid push + flush at proximal IV site. |
| Calcium chloride | 1–2 g IV (10–20 mL of 10%) | Hyperkalemia with ECG changes, calcium channel blocker OD, hypocalcemia. |
| Calcium gluconate | 3 g IV (30 mL of 10%) | Same indications. 3× less elemental calcium than CaCl₂. Safer peripherally. |
| Sodium bicarbonate | 1 mEq/kg IV | Severe metabolic acidosis, TCA overdose, hyperkalemia (adjunct). |
| Magnesium | 2 g IV over 15 min | Torsades de pointes. Also hypomagnesemia-related arrhythmias. |
| Vasopressin (Pitressin) | 40 units IV × 1 | Can replace first or second epi dose in cardiac arrest (AHA 2020 removed specific recommendation but still acceptable). |
| Decision | What to do (2025 AHA) | Why |
|---|---|---|
| Who | Every adult who does not follow verbal commands after ROSC, whatever the rhythm and wherever the arrest happened (Class 1). That includes the in-hospital PEA arrest on the ward, not only the out-of-hospital VF arrest. | The brain injury is from ischemia and reperfusion, which does not depend on rhythm or location. Excluding non-shockable or in-hospital arrests is a habit left over from the 2002 trials, which enrolled only witnessed shockable arrests. |
| Target | Pick one constant temperature between 32 and 37.5°C (89.6 to 99.5°F) and hold it (Class 1). Two common protocols: normothermia 36 to 37.5°C (96.8 to 99.5°F) with a feedback device, or hypothermia 32 to 34°C (89.6 to 93.2°F) followed by normothermia. Use a core probe (esophageal or bladder), not an axillary or tympanic reading. | TTM2, 2021 found no difference between 33°C (91.4°F) and normothermia, and hypothermia caused more arrhythmia with hemodynamic compromise. The pooled trials do not exclude a benefit at lower temperatures and none showed harm, which is why the whole range stays acceptable. Whether sicker patients do better colder is unknown (Class 2b). |
| How long | At least 36 hours of total temperature control (Class 2a). The clock covers the whole period of active management: the hypothermic phase, if one is used, plus the normothermic fever-prevention phase after it. Many units still run the 72 hours used in the TTM trials, which the guideline permits: 36 hours is the floor. | BOX, 2023 compared 36 with 72 hours of device-based control and found no difference in death or severe disability (32.3% vs 33.6%), which is where the 36-hour floor comes from. Fever after the first 24 hours is still associated with poor outcome, so stopping the device is not the end of fever prevention. |
| How | A device with temperature feedback, surface pads or an intravascular catheter; both are acceptable, and the same machines serve both strategies (see the comparison below). Ice packs and fans overshoot and drift. Rapid cold IV saline before hospital arrival is not recommended (Class 3, no benefit). | Prehospital cold-fluid loading showed no outcome benefit and a signal of harm (re-arrest and pulmonary edema). In hospital, cold saline is still used by some protocols to speed induction (the TTM2 hypothermia arm allowed it), but it is a volume load into a heart that is usually stunned, and it cannot hold a target: the feedback device does that. |
| Shivering | Treat it early and in steps: scheduled acetaminophen, skin counter-warming, buspirone and magnesium first; then sedation (Propofol (Diprivan) 5-50 mcg/kg/min) and Meperidine (Demerol) 25-50 mg IV PRN; neuromuscular blockade last, ideally with EEG monitoring in place. | Shivering generates heat and raises oxygen consumption, so it fights the device and defeats the target. Paralysis hides seizures, which is why EEG should be running before it is used. |
| Rewarming | No faster than 0.5°C per hour (0.9°F per hour) (Class 2b), whether coming out of a hypothermic target or treating a patient who arrived spontaneously cold after ROSC. Trials used 0.25 to 0.5°C per hour (0.45 to 0.9°F per hour). | Fast rewarming causes vasodilation with hypotension, a potassium shift back out of cells, and rebound hyperthermia. Spontaneous hypothermia after ROSC usually marks a more severe brain injury, so do not rewarm it aggressively. |
| Expect at low targets | Bradycardia (leave it alone if the MAP is adequate), cold diuresis with hypokalemia and hypomagnesemia, insulin resistance, mild coagulopathy, and slowed clearance of sedatives and opioids. | Replace potassium cautiously while cold, because it shifts back out of cells on rewarming and overcorrection produces hyperkalemia at exactly the wrong time. Slowed drug clearance is one reason the prognostication clock starts late. |
| Prognosis | No neuroprognostication until at least 72 hours after return to normothermia AND off sedation (Class 2a), and never on a single finding: exam, EEG, SSEP, imaging and biomarkers together (Class 1). | Sedatives, cold and the early post-injury period all suppress the exam and mimic a devastating injury. Withdrawing care on an early exam becomes a self-fulfilling prophecy. |
| Inducing hypothermia (32 to 34°C / 89.6 to 93.2°F) | Preventing fever (36 to 37.5°C / 96.8 to 99.5°F) | |
|---|---|---|
| Device | Required from the start. Surface: adhesive hydrogel pads or water-circulating wraps with a feedback console. Intravascular: a femoral or central cooling catheter that circulates cold saline inside balloons (closed loop, nothing is infused). Intravascular tends to hold the target more tightly; surface is faster to set up and needs no line. | The same devices, set higher. Pads or catheter set to 36 to 37.5°C, either from the start or the moment the temperature crosses the trigger (37.8°C / 100°F in TTM2). In TTM2, 2021, 46% of the normothermia arm still needed a device, so have one at the bedside: about half of patients need more than antipyretics. |
| Getting to target | Induce as fast as practical: device on maximum, ice packs to groin, axillae and neck as a bridge, and in some protocols cold (4°C / 39°F) crystalloid as an adjunct if the heart and lungs can take the volume. Sedate and control shivering first, because a shivering patient will not cool. | Nothing to induce. Many patients arrive mildly cool (around 35 to 36°C / 95 to 96.8°F) after an arrest. Do not actively warm a mildly cool patient; let them drift up slowly (no faster than 0.5°C / 0.9°F per hour) and cap them at the target. |
| Drugs | Antipyretics do not produce hypothermia. The drugs here are for shivering and sedation: scheduled acetaminophen, buspirone, magnesium, then Propofol (Diprivan) or Dexmedetomidine (Precedex), Meperidine (Demerol), and neuromuscular blockade for refractory shivering. | Scheduled acetaminophen as the base layer, plus the device. Exposure, fans and cool room air are adjuncts only. Look for and treat an infectious source (aspiration pneumonia is common after CPR), but do not wait for cultures before controlling the temperature: in this brain the fever itself is the injury. |
| Workload and side effects | Deeper sedation, more shivering, bradycardia, cold diuresis with potassium and magnesium shifts, insulin resistance, mild coagulopathy, slowed drug clearance, and more arrhythmia with hemodynamic compromise in TTM2. Needs a controlled rewarming phase. | Lighter sedation, little shivering, fewer electrolyte shifts, no rewarming phase, and an earlier clean neurologic exam. This is why most US units now default here. |
| Monitoring | Continuous core temperature wired to the device: esophageal probe is the most responsive; a bladder probe reads falsely when urine output is low; an intravascular catheter carries its own sensor. Skin, axillary and tympanic readings lag and mislead. Check potassium, magnesium and glucose every 4 to 6 hours while at a hypothermic target and through rewarming. EEG for anyone not following commands, and before any paralytic. | |
| The clock | Typical: about 24 hours at target, rewarm at 0.25 to 0.5°C (0.45 to 0.9°F) per hour, then keep the device on for fever prevention. The whole sequence counts toward the 36-hour minimum; the TTM trials ran 72. | Device on for at least 36 hours total. BOX, 2023 ran 36°C for 24 hours, then 37°C, and found 36 hours no worse than 72. After the device comes off, keep treating any fever. |
| Trigger | First Steps | Think |
|---|---|---|
| Acute desaturation | O₂, check SpO₂ probe, auscultate, CXR, ABG | PE, mucus plug, PTX, flash pulm edema, pneumonia, aspiration |
| Acute hypotension | Passive leg raise (NOT Trendelenburg -no evidence), IVF bolus, HR check, 12-lead ECG | Sepsis, hemorrhage, PE, cardiogenic, anaphylaxis, adrenal crisis |
| Tachycardia | 12-lead ECG, BP, fluid status, pain assessment | SVT, Afib/RVR, PE, sepsis, hypovolemia, pain, anxiety, withdrawal |
| Acute AMS | Glucose, O₂, vitals, pupils, review meds | Hypoglycemia, opioids, stroke, seizure (postictal), sepsis, hypercarbia |
| Acute chest pain | 12-lead ECG within 10 min, troponin, vitals, O₂ | ACS, PE, dissection, PTX, pericarditis |